These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3. Xu Y, Huang Z, Liu Y. Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560 [Abstract] [Full Text] [Related]
11. MiR-4728-3p could act as a marker of HER2 status. Li H, Zhou X, Zhu J, Cheng W, Zhu W, Shu Y, Liu P. Cancer Biomark; 2015 Nov; 15(6):807-14. PubMed ID: 26406406 [Abstract] [Full Text] [Related]
15. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P. Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488 [Abstract] [Full Text] [Related]
17. Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Kiyose S, Igarashi H, Nagura K, Kamo T, Kawane K, Mori H, Ozawa T, Maeda M, Konno K, Hoshino H, Konno H, Ogura H, Shinmura K, Hattori N, Sugimura H. Pathol Int; 2012 Nov; 62(11):728-34. PubMed ID: 23121603 [Abstract] [Full Text] [Related]
18. Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia. Fox SB, Kumarasinghe MP, Armes JE, Bilous M, Cummings MC, Farshid G, Fitzpatrick N, Francis GD, McCloud PI, Raymond W, Morey A. Am J Surg Pathol; 2012 Apr; 36(4):577-82. PubMed ID: 22314190 [Abstract] [Full Text] [Related]